
Harrow Health Inc (HROW)
US$ 42.446.9%
Price Chart
Key Statistics
Market Cap
$ 980.98M
P/E Ratio
0.00
Revenue (TTM)
$ 212.86M
Volume
585.84K
52W High
$ 59.23
52W Low
$ 16.71
Dividend Yield
0.00%
Beta
0.41
Technicals
50-Day MA
25.2642
200-Day MA
35.5793
52 Week High
59.23
52 Week Low
16.71
About HROW
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
Employees
382
Headquarters
Nashville, TN
CEO
Mr. Mark L. Baum J.D.
Latest News
Harrow Eyes Record $280M Revenue in 2025: Inside the Growth Strategy - Stock Titan
2025-03-17 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg